Research and analysis

Process evaluation of the Catalyst programmes

The report, 'Process evaluation of the Catalyst programmes', details the Catalysts on biotechnology, energy and agriculture technology launched by Innovate UK.

• From: Department for Science, Innovation and Technology, Innovate UK, Foreign, Commonwealth & Development Office, UK Research and Innovation and Department for International Development
  Show 3 more
  Engineering and Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, and Department for Business, Energy & Industrial Strategy
• Published: 28 March 2019
• Last updated: 1 April 2019 — See all updates

Documents

Process evaluation of the Catalyst programmes

PDF, 2.43 MB, 164 pages

Details

Throughout 2013 and 2014, Innovate UK launched 3 Catalysts – joint programmes with cross-government support – designed to support development in biotechnology, energy and agriculture technology.

Catalysts support early stage feasibility studies, industrial stage research and experimental development grants. A total of £224 million was invested by:

• the Department for Business, Energy and Industrial Strategy
• Innovate UK
• the Department for International Development
• the Biotechnology and Biological Sciences Research Council
• the Engineering and Physical Sciences Research Council

The report, ‘Process evaluation of the Catalyst programme’, was commissioned in September 2017 to evaluate the effectiveness of the processes used in programmes and assess how and which Catalysts support or inhibit future impact.

Key findings of the report include:

• effective promotion and marketing, in partnership with the Knowledge Transfer Network (KTN), led to strong demand for the Catalysts programmes
• each Catalyst was perceived to have a balanced portfolio of projects, including potentially transformative and ‘game changing’ technologies
• the creation of good practices relevant to future Catalyst-type interventions

Find out more about the transformation of drug development company, CellCentric, supported by the Industrial Biomedical Catalyst

Published 28 March 2019
Last updated 1 April 2019 + show all updates

1. 1 April 2019

   The document has been replaced with a corrected version. Corrections were made to 'error file not found' messages in several places.

2. 28 March 2019

   First published.